For the year ending 2025-12-31, RAPH has $53K in assets.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 45 | |||
| Other current assets | 6 | |||
| Total current assets | 51 | |||
| Fixed asset, net | 2 | |||
| Total assets | 53 | |||
| Other accounts payable and accrued expenses | 506 | |||
| Short-term credit from a related party | 34 | |||
| Payable to related party | 946 | |||
| Total current liabilities | 1,486 | |||
| Common stock, 0.01 par value authorized 21,020,560 shares issued and outstanding 20,176,418 and 18,701,418 as of december 31, 2025 and december 31, 2024, respectively | 202 | |||
| Additional paid-in capital | 8,533 | |||
| Accumulated deficit | -10,168 | |||
| Total stockholders equity (deficit) | -1,433 | |||
| Total liabilities and stockholders equity | 53 | |||
Raphael Pharmaceutical Inc. (RAPH)
Raphael Pharmaceutical Inc. (RAPH)